Drug Shortage Report for ADMELOG SOLOSTAR

Last updated on 2022-05-12 History
Report ID 160261
Drug Identification Number 02469871
Brand name ADMELOG SOLOSTAR
Common or Proper name Insulin lispro
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 3 mL pre-filled pen, 5 pens/box
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-05-05
Estimated end date 2022-05-13
Actual end date 2022-05-11
Shortage status Resolved
Updated date 2022-05-12
Company comments Delay in transportation. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-05-10 English Compare
v2 2022-05-10 English Compare
v3 2022-05-10 French Compare
v4 2022-05-12 English Compare

Showing 1 to 4 of 4